High and low doses with increased IMT, moderate (0.15–0.4 mg/kg/day) doses with decreased IMT in children [26] and adults [27] IMT: Intima-media thickness; SLE: Systemic lupus erythematosus ...

CVD is the leading cause of death for people with systemic lupus erythematosus (SLE), the most common type of lupus. What’s the Connection Between Lupus and Heart Disease?

Women with immune-mediated inflammatory diseases (IMIDs) face higher CVD-related mortality rates than do men, according to recently published research.

Patients with systemic lupus erythematosus (SLE) are at increased risk of cardiovascular disease (CVD), say researchers, who explored the risk as it relates to factors like excess weight, disease ...

Cardiovascular disease (CVD) is a major complication for people with systemic lupus erythematosus (SLE), but a considerable amount of research is pointing toward biomarkers for risk stratification ...

In those patients with SLE, cardiovascular disease is a major cause of illness and mortality with recent studies suggesting 36% of all SLE-related deaths are attributed to ischemic heart disease.

In those patients with SLE, cardiovascular disease is a major cause of illness and mortality with recent studies suggesting 36% of all SLE-related deaths are attributed to ischemic heart disease.

KEY POINTS Both patient and clinician should be aware that systemic lupus erythematosus (SLE) increases the risk for cardiovascular disease, including a 10-fold increased risk of nonfatal MI and a ...

Incidence rates of ASCVD were highest for individuals with SLE, followed by CLE, psoriasis, and controls at a median follow-up of three years (24.8, 15.2, 14.0, and 10.3 per 1000 person-years ...

A recent study by researchers at Penn State College of Medicine found significant racial disparities in the age of systemic lupus erythematosus (SLE) patients at the time of hospital admission for ...

High and low doses with increased IMT, moderate (0.15–0.4 mg/kg/day) doses with decreased IMT in children [26] and adults [27] IMT: Intima-media thickness; SLE: Systemic lupus erythematosus ...

Incidence rates of ASCVD were highest for individuals with SLE, followed by CLE, psoriasis, and controls at a median follow-up of three years (24.8, 15.2, 14.0, and 10.3 per 1,000 person-years ...